News Archive

/static/apps/cms/news/1658/Humble, Robert 500.jpg

Publication on Diagnosis of Renal Cell Carcinomas Supports Enhanced Patient Care

July 21, 2025 / Kidney Cancer

One of the defining characteristics of Michigan Medicine’s Department of Pathology is its commitment to broadly sharing expertise to ensure patients everywhere receive the best care possible. Recently, Pathology faculty, Robert Humble, MD, Rahul Mannan, MD, and Rohit Mehra, MD published an article in Kidney Cancer describing the most recent advances in diagnosing renal neoplasia, including their morphological context, diagnostic algorithm, and available molecular biomarkers to assist pathologists in correctly identifying renal cell carcinomas (RCC) of varying types. In addition, whenever possible, they also provided a brief summary of the current therapeutics that align with each subtype of RCC.

FULL STORY
/static/apps/cms/news/1110/Dressler_500x500.jpg

Two Proteins Critical for Kidney Function

March 24, 2021 / Faculty

Research by Drs. Ann Laszczyk and the Department of Pathology's Dr. Gregory Dressler was just published in the Journal of the American Society of Nephrology. The study focuses on PAX2 proteins and their effects on kidney function and development.

FULL STORY
/static/apps/cms/news/956/Rohit-Header-LG-Apr14-2020.jpg

Diagnostic Biomarkers Uncovered for Rare Kidney Cancer

April 21, 2020 / Experimental Pathology

Researchers have uncovered the gene signature for ChRCC.

FULL STORY